On the other hand, differences in the associations of the modifying polymorphisms with breast cancer risk for BRCA1 and BRCA2 mutation carriers are likely to reflect differences in the biology of tumor development in these two groups of women at high risk of BC. Here, BRCA2 is linked to neoplasm.